Page last updated: 2024-08-17

ficusin and cyclosporine

ficusin has been researched along with cyclosporine in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (11.11)	18.2507
2000's	6 (66.67)	29.6817
2010's	1 (11.11)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Dinndorf, PA; Jubran, RF	1
Adler, KR; Bisaccia, E; Goldberg, SL; Gonzalez, J; Palangio, M; Rowley, SD	1
Feldman, SR; Margolis, DJ; Nijsten, T; Rolstad, T	1
Naldi, L; Rzany, B	1
Feldman, SR; Margolis, DJ; Nijsten, T; Rolstad, T; Stern, RS	1
Griffiths, CE; Naldi, L	1
Bolesani, F; Caffieri, S; Canton, M; Dall'Acqua, F; Di Lisa, F; Facco, M; Semenzato, G	1
Aksoy, Y; Karaduman, A; Pinar, A; Yıldırım, FE	1

Reviews

2 review(s) available for ficusin and cyclosporine

Article	Year
Chronic plaque psoriasis. Clinical evidence, 2004, Issue:11 Topics: Anthralin; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Ficusin; Humans; Nicotinic Acids; Psoriasis; Retinoids; Ultraviolet Therapy; Vitamin D	2004
Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. The British journal of dermatology, 2005, Volume: 152, Issue:4 Topics: Administration, Oral; Chronic Disease; Cyclosporine; Dermatologic Agents; Ficusin; Fumarates; Humans; Immunosuppressive Agents; Methotrexate; Photosensitizing Agents; Psoriasis; PUVA Therapy; Retinoids; Risk Assessment; Ultraviolet Therapy	2005

Article

Year

Chronic plaque psoriasis.

Clinical evidence, 2004, Issue:11

Topics: Anthralin; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Ficusin; Humans; Nicotinic Acids; Psoriasis; Retinoids; Ultraviolet Therapy; Vitamin D

2004

Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.

The British journal of dermatology, 2005, Volume: 152, Issue:4

Topics: Administration, Oral; Chronic Disease; Cyclosporine; Dermatologic Agents; Ficusin; Fumarates; Humans; Immunosuppressive Agents; Methotrexate; Photosensitizing Agents; Psoriasis; PUVA Therapy; Retinoids; Risk Assessment; Ultraviolet Therapy

2005

Trials

1 trial(s) available for ficusin and cyclosporine

Article	Year
CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy. International journal of dermatology, 2011, Volume: 50, Issue:8 Topics: Adenosine Deaminase; Adult; Aged; Aged, 80 and over; Biomarkers; Cyclosporine; Dipeptidyl Peptidase 4; Etanercept; Female; Ficusin; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Psoriasis; Receptors, Tumor Necrosis Factor; Ultraviolet Therapy; Young Adult	2011

Article

Year

CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy.

International journal of dermatology, 2011, Volume: 50, Issue:8

Topics: Adenosine Deaminase; Adult; Aged; Aged, 80 and over; Biomarkers; Cyclosporine; Dipeptidyl Peptidase 4; Etanercept; Female; Ficusin; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Psoriasis; Receptors, Tumor Necrosis Factor; Ultraviolet Therapy; Young Adult

2011

Other Studies

6 other study(ies) available for ficusin and cyclosporine

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Successful therapy of refractory graft versus host disease with tacrolimus and Psoralen plus ultraviolet light. Therapeutic drug monitoring, 1998, Volume: 20, Issue:2 Topics: Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Ficusin; Globulins; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Methylprednisolone; Photosensitizing Agents; Radiotherapy, Adjuvant; Tacrolimus; Ultraviolet Therapy	1998
Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy. Bone marrow transplantation, 2003, Volume: 31, Issue:4 Topics: Adult; Chronic Disease; Cyclosporine; Ficusin; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Middle Aged; Photochemotherapy; Prednisone; Ultraviolet Rays	2003
Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing. Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:1 Topics: Acitretin; Cyclosporine; Female; Ficusin; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Methotrexate; Middle Aged; Patient Satisfaction; Photosensitizing Agents; Psoriasis; PUVA Therapy; Treatment Outcome	2005
Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:3 Pt 1 Topics: Acitretin; Adult; Aged; Cyclosporine; Dermatologic Agents; Female; Ficusin; Health Surveys; Humans; Male; Methotrexate; Middle Aged; Patient Satisfaction; Psoriasis; PUVA Therapy; Treatment Outcome; United States	2005
The mitochondrial effects of novel apoptogenic molecules generated by psoralen photolysis as a crucial mechanism in PUVA therapy. Blood, 2007, Jun-01, Volume: 109, Issue:11 Topics: Animals; Apoptosis; Cyclosporine; Cytochromes c; Ficusin; Humans; Jurkat Cells; Mitochondria; Photolysis; Photosensitizing Agents; PUVA Therapy; Rats; Rats, Wistar; Ultraviolet Rays; Umbelliferones	2007